| View |
|
DR-XY25991
|
Ferrous Sulfate
|
None
|
325 mg
|
Tablet
|
Anti-anemic
|
Pharmatechnica Laboratory, Inc
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
23 March 2027
|
| View |
|
DR-XY25993
|
Ascorbic Acid (Vitamin C)
|
Nutricee
|
500 mg
|
Chewable Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
19 February 2020
|
23 February 2025
|
| View |
|
DR-XY26004
|
Bisoprolol Fumarate + Hydrochlorothiazide
|
Ziac
|
2.5 mg / 6.25 mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker/Diuretic/Antihypertensive
|
PT. Merck, Tbk.
|
Indonesia
|
Renewal
|
11 July 2024
|
12 January 2030
|
| View |
|
DR-XY26026
|
Aescin + Diethylamine Salicylate
|
Reparil-N-Gel
|
1 g/5 g per 100 g
|
Gel
|
-
|
Madahaus GmbH
|
Germany
|
-
|
06 May 2020
|
15 March 2025
|
| View |
|
DR-XY26031
|
Cefalexin
|
None
|
250 mg/ 5 mL
|
Powder For Suspension
|
-
|
Asian Antibiotics, Inc
|
Philippines
|
-
|
31 January 2020
|
15 March 2025
|
| View |
|
DR-XY26032
|
Cefalexin
|
None
|
100 mg/ mL
|
Powder For Suspension (Oral Drops)
|
-
|
Asian Antibiotics, Inc
|
Philippines
|
-
|
31 January 2020
|
15 March 2025
|
| View |
|
DR-XY26037
|
Cefuroxime (As Sodium)
|
Panaxim
|
750 mg
|
Powder For Injection (IM/IV)
|
-
|
Panpharma
|
France
|
-
|
17 February 2022
|
20 March 2025
|
| View |
|
DR-XY26038
|
Cefazolin
|
Fonvicol
|
1 g
|
Powder For Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Panpharma
|
France
|
Renewal
|
17 February 2022
|
20 March 2025
|
| View |
|
DR-XY26039
|
Ampicillin Sodium
|
Panacta
|
500 mg
|
Powder for Injection (IM/IV)
|
-
|
Panpharma
|
France
|
-
|
11 March 2022
|
20 March 2025
|
| View |
DR-XY26041_PI_01.pdf
|
DR-XY26041
|
Goserelin Acetate (Equivalent To Goserelin Base)
|
Zoladex® LA
|
10.8 mg
|
Depot Solution For Subcutaneous Injeciton
|
-
|
AstraZeneca UK Ltd.
|
Indonesia
|
Initial (Variation)
|
16 November 2022
|
16 November 2027
|
| View |
|
DR-XY26072
|
Diclofenac Sodium
|
Lobafen
|
50mg
|
Tablet
|
-
|
San Marino Laboratories Corporation
|
Philippines
|
-
|
27 January 2021
|
03 December 2025
|
| View |
|
DR-XY26083
|
Ambroxol Hydrochloride
|
Cofalixir
|
15 mg/5 mL
|
Syrup
|
Mucolytic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 March 2023
|
04 April 2028
|
| View |
|
DR-XY26102
|
Fusidic Acid + Hydrocortisone
|
Fucidin H
|
20mg/ 10mg per gram
|
Cream
|
Antibacterial/Corticosteriod
|
Leo Laboratories Ltd.
|
Ireland
|
Automatic Renewal
|
20 January 2022
|
25 January 2027
|
| View |
|
DR-XY26111
|
Amoxicillin (As Trihydrate)
|
Nixolin
|
500 mg
|
Capsule
|
-
|
LLOYD LABORATORIES, INC.
|
Philippines
|
-
|
17 February 2021
|
12 April 2025
|
| View |
|
DR-XY26113
|
Mefenamic Acid
|
Algicap
|
50 mg/5 mL
|
Oral Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
26 March 2020
|
10 April 2025
|
| View |
|
DR-XY26134
|
Fludarabine Phosphate
|
Fludara
|
50mg
|
Powder For Injection (IV)
|
-
|
Baxter Oncology GmbH
|
switzerland
|
Initial (from Monitored Release)
|
26 October 2022
|
05 May 2025
|
| View |
|
DR-XY2615
|
Furosemide + Potassium chloride
|
Diumide-K
|
40mg/600mg
|
Film-Coated Tablet
|
Diuretic
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 April 2022
|
09 May 2027
|
| View |
|
DR-XY26153
|
Propofol
|
Fresofol 1%
|
10 mg/mL
|
Emulsion for Intravenous Infusion
|
-
|
Fresenius Kabi Austria GmbH
|
Austria
|
-
|
18 March 2020
|
03 May 2025
|
| View |
|
DR-XY26178
|
Acetylcysteine
|
Fluimucil
|
100 mg/ mL
|
Solution For Injection (I.M./ I.V.)
|
-
|
Zambon S.p.A.
|
Italy
|
-
|
13 February 2020
|
11 May 2025
|
| View |
DR-XY26190_PI_01.pdf
|
DR-XY26190
|
Fenofibrate
|
Lipanthyl
|
67 mg
|
Capsule
|
-
|
Recipharm Fontaine
|
France
|
-
|
06 April 2020
|
12 May 2025
|